The Biosimilar Contract Manufacturing Market segment is categorized based on therapy type, scale of operation, and service offerings. Clinical applications for oncology, autoimmune diseases, and metabolic disorders drive significant demand. CMOs provide end-to-end solutions including cell line development, upstream and downstream processing, analytical testing, and formulation. These segments...